Skip to main content
Daniel Johnson, MD, Oncology, New Orleans, LA

Daniel Johnson MD

Oncology•New Orleans, LA

Hematology Oncology Fellow

Join to View Full Profile

  • 1514 Jefferson HwyNew Orleans, LA 70121

  • Phone+1 504-842-2873

  • Fax+1 504-842-4533

Dr. Johnson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Johnson's Full ProfileAlready have an account?

Education & Training

  • Louisiana State University School of Medicine in New Orleans
    Louisiana State University School of Medicine in New OrleansClass of 2012
  • Louisiana State University
    Louisiana State UniversityFellowship, Medical Oncology
  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 2019 - 2025
  • AL State Medical License
    AL State Medical License 2020 - 2024
  • MS State Medical License
    MS State Medical License 2019 - 2020
  • TX State Medical License
    TX State Medical License 2017 - 2020
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Interleukin-6 is potential target to de-couple checkpoint inhibitor-induced colitis from antitumor immunity. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

  • Q&A: The Evolving Role of Antibody-Drug Conjugates in Oncology
    Q&A: The Evolving Role of Antibody-Drug Conjugates in OncologyAugust 20th, 2024
  • NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
    NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)November 7th, 2018
  • Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim Meeting
    Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim MeetingNovember 14th, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Daniel Johnson, Dr. Daniel Johnson, MD, Dr. D Johnson